Skip to main content

The context you need, when you need it

When news breaks, you need to understand what actually matters — and what to do about it. At Vox, our mission to help you make sense of the world has never been more vital. But we can’t do it on our own.

We rely on readers like you to fund our journalism. Will you support our work and become a Vox Member today?

Join now

Google Life Sciences, Alphabet’s Health Care Moonshot Lab, Is Now Called ‘Verily’

Verily, I swear.

Google

Here come the Alphabet soup renames. Yesterday it was Google Ventures, the conglomerate’s venture arm, which is now just GV.

Today it’s Google Life Sciences, the experimental health care lab that spun out of Google X. Henceforth, it is “Verily.”

The Alphabet company is led by respected biologist Andy Conrad. Linus Upson, a 10-year Google vet who co-founded the Chrome browser with CEO Sundar Pichai, joined as head of engineering in May. As we reported earlier, Upson has been in talks with a leading geneticist about a potential genetic engineering project.

Here’s how the company describes itself on its new site: “Our multidisciplinary teams have access to advanced research tools, large scale computing power, and unique technical expertise. We work with partners from across the industry and many fields of research to develop new technology, launch studies, and start companies.” (It has yet to claim the Verily Twitter handle.)

The unit made its debut inside Google X with the smart contact lens. It entered a licensing agreement with pharmaceutical giant Novartis to sell that device, and has cut other deals around hardware and digital platforms for the treatment of diabetes. Last month, the company said that heart disease would be its next major focus. It also hired the top mental health scientist from the National Institutes of Health.

While the company has, thus far, stuck to partnerships, its three-tiered focus — on medical software, high-tech gadgets and clinical research — may pit Verily against companies in the pharmaceutical industry as well as tech companies, like IBM, moving into biotech.

As for the name: It’s Middle English for “truly.” “Only through the truth are we going to defeat Mother Nature,” Conrad told the health publication Stat News.

“Verily, I swear, ’tis better to be lowly born,
And range with humble livers in content,
Than to be perk’d up in a glistering grief,
And wear a golden sorrow.”

Shakespeare gave that line to Anne Boleyn in “Henry VIII.” She was beheaded.

This article originally appeared on Recode.net.

More in Technology

Podcasts
Are humanoid robots all hype?Are humanoid robots all hype?
Podcast
Podcasts

AI is making them better — but they’re not going to be doing your chores anytime soon.

By Avishay Artsy and Sean Rameswaram
Future Perfect
The old tech that could help stop the next airborne pandemicThe old tech that could help stop the next airborne pandemic
Future Perfect

Glycol vapors, explained.

By Shayna Korol
Future Perfect
Elon Musk could lose his case against OpenAI — and still get what he wantsElon Musk could lose his case against OpenAI — and still get what he wants
Future Perfect

It’s not about who wins. It’s about the dirty laundry you air along the way.

By Sara Herschander
Life
Why banning kids from AI isn’t the answerWhy banning kids from AI isn’t the answer
Life

What kids really need in the age of artificial intelligence.

By Anna North
Culture
Anthropic owes authors $1.5B for pirating work — but the claims process is a Kafkaesque messAnthropic owes authors $1.5B for pirating work — but the claims process is a Kafkaesque mess
Culture

“Your AI monster ate all our work. Now you’re trying to pay us off with this piece of garbage that doesn’t work.”

By Constance Grady
Future Perfect
Some deaf children are hearing again because of a new gene therapySome deaf children are hearing again because of a new gene therapy
Future Perfect

A medical field that almost died is quietly fixing one disease at a time.

By Bryan Walsh